1-1 of 1
Byung-gyu Kim, DVM
Close
Sort by
Journal Articles

Rethinking Risk-Benefit Assessment for Phase I Multiple Myeloma Trials

Ehsan Malek, MD, Caner Saygin, MD, Rebecca Ye, Byung-gyu Kim, DVM, Fahrettin Covut, MD, Marcos De Lima, MD, James J. Driscoll, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1146.
https://doi.org/10.1182/blood.V128.22.1146.1146
Published: 2016